Search
for
Sort by
Research 931–960 of 1000+
- Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
- dsRNA Released by Tissue Damage Activates TLR3 to Drive Skin Regeneration
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Increased Expression of Zyxin and Its Potential Function in Androgenetic Alopecia
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- FLCN regulates transferrin receptor 1 transport and iron homeostasis
- Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- 186 Mechanistic insights into Ritlecitinib-mediated immunomodulation in Alopecia Areata
- Biomedical Applications of Bee Venom: A Natural Approach to Cancer, Infections, and Inflammatory Diseases
- Effects of oxytocin receptor agonists on hair growth promotion
- Application of Non-Pharmacologic Therapy in Hair Loss Treatment and Hair Regrowth
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Analysis of histology and long noncoding RNAs involved in the rabbit hair follicle density using RNA sequencing
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Bletilla striata polysaccharide-based dissolving microneedle patch integrated with nanoparticles for promoting hair regrowth
- Immortalized human hair follicle-derived mesenchymal-like stromal cells for the long-term production of scalable Immunomodulatory and regenerative secretome
- Iron–Skin Axis: Exploring the Interplay between Iron Homeostasis and Skin Disorders
- Reconsidering the classification of vitiligo and alopecia as cosmetic concerns in Medicaid and Tricare policies
- Upadacitinib for the treatment of alopecia areata – A case report
- Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients
- Androgenetik Alopesi
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy